DCR:盆腔外侧淋巴结清扫术后局部晚期直肠癌的复发危险因素分析

2021-12-12 MedSci原创 MedSci原创

1.早期直肠癌多数无症状。2.直肠癌生长 到一定程度时出现排便习惯改变、血便、脓血便、里急后重、便秘、腹泻等。3.大便 逐渐变细,晚期则有排便梗阻、消瘦甚至恶病质。

      直肠癌目前的手术方式是全直肠系膜切除(TME),然而,在局部晚期下直肠癌 (LALRC)患者中单纯根治性手术容易导致局部复发率 (LRR) 较高。盆腔外侧淋巴结清扫术 (LPLND)是一种保留盆腔自主神经的新型一种治疗选择,它与新辅助放化疗控制局部复发 (LR) 的疗效相似。有研究显示盆腔外侧淋巴结转移与更高的 LR 发生率相关。因此,本研究的目的是分析术前因素与晚期直肠癌局部复发之间的关系,并评估接受外侧盆腔淋巴结清扫术的局部晚期下直肠癌患者的局部复发危险因素。

 

      为了完成本项研究,研究人员纳入了469例2010年至2018年间接受根治性切除术和盆腔外侧淋巴结清扫术的局部晚期直肠下段腺癌患者。然后使用多变量 Cox 回归评估局部复发的独立危险因素,并将局部复发分为 3 个区域,评估了不同部位的复发风险。

 

      研究结果显示共有286例患者接受了手术,132例患者接受了新辅助化疗后手术,51例患者接受了术前放化疗后手术。86例(18.3%)存在盆腔壁外静脉浸润阳性,113例(24.1%)环周切缘阳性。中位随访期为 46 个月。局部复发显示与壁外静脉浸润阳性(HR = 2.596(95% CI,1.321–5.102);p = 0.006)或环周切缘阳性(HR = 2.298(95% CI,1.158–4.560);p= 0.017)。局部复发率51例(10.8%),以盆腔神经丛和髂内区最常见(6.6%),其次是中央骨盆区(3.8%),闭孔区明显几率较低(0.4%)。

 

 

      本项研究结果证实在接受外侧盆腔淋巴结清扫术的患者中,壁外静脉浸润状态和环周切缘状态与高局部复发率相关。此外,闭孔区的局部复发率低于其他区域。

 

 

原始出处:

Shiraishi, Takuya. Et al. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection. Diseases of the Colon & Rectum.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1973361, encodeId=eb3f19e336193, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Mon Oct 24 15:14:30 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023132, encodeId=9f5b2023132a0, content=<a href='/topic/show?id=c19d4e61952' target=_blank style='color:#2F92EE;'>#局部晚期直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47619, encryptionId=c19d4e61952, topicName=局部晚期直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f76619, createdName=gj0731, createdTime=Tue Feb 01 16:14:30 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650833, encodeId=bc5f1650833a6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47614, encryptionId=ffae4e614b6, topicName=局部晚期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901d24099859, createdName=yhy100208, createdTime=Wed Apr 13 04:14:30 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293148, encodeId=163412931487b, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406135, encodeId=550714061356d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590181, encodeId=f0dd1590181e1, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1973361, encodeId=eb3f19e336193, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Mon Oct 24 15:14:30 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023132, encodeId=9f5b2023132a0, content=<a href='/topic/show?id=c19d4e61952' target=_blank style='color:#2F92EE;'>#局部晚期直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47619, encryptionId=c19d4e61952, topicName=局部晚期直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f76619, createdName=gj0731, createdTime=Tue Feb 01 16:14:30 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650833, encodeId=bc5f1650833a6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47614, encryptionId=ffae4e614b6, topicName=局部晚期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901d24099859, createdName=yhy100208, createdTime=Wed Apr 13 04:14:30 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293148, encodeId=163412931487b, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406135, encodeId=550714061356d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590181, encodeId=f0dd1590181e1, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1973361, encodeId=eb3f19e336193, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Mon Oct 24 15:14:30 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023132, encodeId=9f5b2023132a0, content=<a href='/topic/show?id=c19d4e61952' target=_blank style='color:#2F92EE;'>#局部晚期直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47619, encryptionId=c19d4e61952, topicName=局部晚期直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f76619, createdName=gj0731, createdTime=Tue Feb 01 16:14:30 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650833, encodeId=bc5f1650833a6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47614, encryptionId=ffae4e614b6, topicName=局部晚期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901d24099859, createdName=yhy100208, createdTime=Wed Apr 13 04:14:30 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293148, encodeId=163412931487b, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406135, encodeId=550714061356d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590181, encodeId=f0dd1590181e1, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1973361, encodeId=eb3f19e336193, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Mon Oct 24 15:14:30 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023132, encodeId=9f5b2023132a0, content=<a href='/topic/show?id=c19d4e61952' target=_blank style='color:#2F92EE;'>#局部晚期直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47619, encryptionId=c19d4e61952, topicName=局部晚期直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f76619, createdName=gj0731, createdTime=Tue Feb 01 16:14:30 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650833, encodeId=bc5f1650833a6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47614, encryptionId=ffae4e614b6, topicName=局部晚期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901d24099859, createdName=yhy100208, createdTime=Wed Apr 13 04:14:30 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293148, encodeId=163412931487b, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406135, encodeId=550714061356d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590181, encodeId=f0dd1590181e1, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2021-12-14 sodoo
  5. [GetPortalCommentsPageByObjectIdResponse(id=1973361, encodeId=eb3f19e336193, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Mon Oct 24 15:14:30 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023132, encodeId=9f5b2023132a0, content=<a href='/topic/show?id=c19d4e61952' target=_blank style='color:#2F92EE;'>#局部晚期直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47619, encryptionId=c19d4e61952, topicName=局部晚期直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f76619, createdName=gj0731, createdTime=Tue Feb 01 16:14:30 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650833, encodeId=bc5f1650833a6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47614, encryptionId=ffae4e614b6, topicName=局部晚期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901d24099859, createdName=yhy100208, createdTime=Wed Apr 13 04:14:30 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293148, encodeId=163412931487b, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406135, encodeId=550714061356d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590181, encodeId=f0dd1590181e1, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2021-12-14 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=1973361, encodeId=eb3f19e336193, content=<a href='/topic/show?id=b7d8660203a' target=_blank style='color:#2F92EE;'>#淋巴结清扫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66020, encryptionId=b7d8660203a, topicName=淋巴结清扫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Mon Oct 24 15:14:30 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023132, encodeId=9f5b2023132a0, content=<a href='/topic/show?id=c19d4e61952' target=_blank style='color:#2F92EE;'>#局部晚期直肠癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47619, encryptionId=c19d4e61952, topicName=局部晚期直肠癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f76619, createdName=gj0731, createdTime=Tue Feb 01 16:14:30 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650833, encodeId=bc5f1650833a6, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47614, encryptionId=ffae4e614b6, topicName=局部晚期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=901d24099859, createdName=yhy100208, createdTime=Wed Apr 13 04:14:30 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1293148, encodeId=163412931487b, content=<a href='/topic/show?id=df626600877' target=_blank style='color:#2F92EE;'>#淋巴结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66008, encryptionId=df626600877, topicName=淋巴结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406135, encodeId=550714061356d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590181, encodeId=f0dd1590181e1, content=<a href='/topic/show?id=c86e66021c9' target=_blank style='color:#2F92EE;'>#淋巴结清扫术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66021, encryptionId=c86e66021c9, topicName=淋巴结清扫术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dec17785365, createdName=kord1988, createdTime=Tue Dec 14 05:14:30 CST 2021, time=2021-12-14, status=1, ipAttribution=)]

相关资讯

J Sex Med:雄性激素对女性直肠癌患者性功能的影响

接受直肠癌治疗的女性有性功能障碍和卵巢雄性激素分泌受损的风险。

DCR: 慢性肾脏病对接受新辅助放化疗治疗的局部晚期直肠癌患者的预后影响

慢性肾病不是一个病,而是一堆病的统称,如——慢性肾小球肾炎、慢性肾盂肾炎、红斑狼疮肾炎、肾病综合征、糖尿病肾病和高血压肾病等。

Gastroenterology:肠癌防控中国突破:血液多基因甲基化检测可实现结直肠癌早筛和复发预测

这是中国团队首次在全球范围内实现结直肠癌筛查及复发预测技术手段合二为一。常艾克亦是全球第一款具备结直肠癌早期筛查和术后监测复合功能的产品。

预防结直肠癌利器——你必须了解的肠镜检查指南!

肠癌作为一种“行动缓慢”,最易预防的恶性肿瘤,多为肠道息肉发展而来,需在肠息肉阶段及时“止损”。

Radiology:功能MRI的新板块:DSC MRI技术在直肠癌患者中的应用

在2018年,直肠癌已成为全球第八大最常见的癌症。在过去的十年中,全直肠系膜切除术的发展和新辅助治疗的广泛使用使得直肠癌患者的生存率显著提高。